Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Weekly Picks
Alphabet
BL
BlackGoat
Community Contributor
Alphabet: The Under-appreciated Compounder Hiding in Plain Sight
Summary Google trades at ~18× forward earnings; the cheapest among the Magnificent 7 Market is too focused on AI threats to Search and antitrust noise Meanwhile, Google is executing across AI, Cloud, and YouTube Key AI differentiator: unmatched distribution across 3B+ users via Search, Gmail, YouTube, Android, Chrome, and Cloud Quietly building a world-class AI infrastructure behind the scenes; including proprietary TPUs and a vertically integrated stack YouTube generated $8.93B in Q1 ad revenue (up 10% YoY); subscriptions hit 270M Google Cloud revenue up 28% YoY to $12.3B; now profitable Optionality from long-term bets like Waymo, DeepMind, and Verily Risk/reward is compelling; a strong candidate to beat the market long term Overview Despite being part of the "Magnificent Seven," Google’s stock lags due to perceived risks around disruption of its Search business from AI competitors and mounting antitrust concerns. But under the hood, Google has quietly built one of the most compelling setups in tech: with deep AI leadership, multiple high-growth businesses, and optionality from long-term moonshots like Waymo.
View narrative
US$282.83
FV
32.8% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
23
users have liked this narrative
3
users have commented on this narrative
61
users have followed this narrative
Updated
narrative
Planet Labs PBC
AN
andreas_eliades
Community Contributor
Planet Labs: At The Heart Of The Emerging New Space Boom
Planet Labs leads the EO market with the largest satellite constellation, poised to capitalize on the growing demand for Earth Observation and geospatial data from companies and governments. Plunging space launch and GPU computation costs combined with advancements in CubeSat and AI technologies are boosting the utility of Earth Observation data.
View narrative
US$11.31
FV
45.4% undervalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
1
users have commented on this narrative
63
users have followed this narrative
New
narrative
Exxon Mobil
AG
Agricola
Community Contributor
Exxon in Guyana 5 year forecast Low $135 to High $189
Previous mistake rectified. So as pointed out in the comments, Chevron won the Hess bid (rather than Exxon) and took a large portion of the Stabroek block.
View narrative
US$174.00
FV
37.0% undervalued
intrinsic discount
12.97%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Community Investing Ideas
Load previous narratives
Prospera Energy
CA
Canderous
Community Contributor
Even at the under expectation numbers, we are on track to reduce debt and build value
Key Financial Highlights for 2025: Quick Fair Value Estimate (NAV Approach) 1. 2P Reserves (Proved + Probable): 6,793 Mboe (thousands of barrels of oil equivalent) NPV10 (before tax): CAD $159.3 million ➤ Source: 2024 year-end reserves update 2.
View narrative
CA$0.063
FV
44.4% undervalued
intrinsic discount
-2.07%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
about 2 months ago
author updated this narrative
RenovoRx
ST
Stock_Research_Today
Community Contributor
Revolutionizing Cancer Treatment
A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.
View narrative
US$4.20
FV
71.2% undervalued
intrinsic discount
371.30%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
3
users have commented on this narrative
122
users have followed this narrative
about 2 months ago
author updated this narrative
Capstone Holding
CM
CMCVentures
Community Contributor
Scaling up in building materials with smart M&A and growing profitability
Key Takeaways Capstone is building a scalable platform in specialty construction materials, focusing on thin veneer masonry in the U.S. Midwest and Northeast. With a strategy of tuck-in acquisitions, innovative proprietary products, and regional growth, revenue could triple by 2030.
View narrative
US$2.77
FV
48.0% undervalued
intrinsic discount
21.60%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
67
users have followed this narrative
about 2 months ago
author updated this narrative
Silo Pharma
CM
CMCVentures
Community Contributor
Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s
Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.
View narrative
US$6.20
FV
88.3% undervalued
intrinsic discount
234.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
6
users have commented on this narrative
95
users have followed this narrative
about 2 months ago
author updated this narrative
Argan
KE
Kerry
Community Contributor
Argan's Revenue Set to Soar with a 13.31% Growth in the Coming Decade
RECENT PAST AGX has consistently delivered robust revenue growth, with fiscal year 2025 revenue rising 53% year-over-year to $874.2 million and net income surging 164% to $85.5 million. In recent quarters, revenue growth has exceeded 60% year-over-year, particularly fueled by performance in its Power Services segment.
View narrative
US$284.68
FV
20.9% undervalued
intrinsic discount
13.31%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
3
users have commented on this narrative
24
users have followed this narrative
about 2 months ago
author updated this narrative
Occidental Petroleum
DZ
Dzitkowskik
Community Contributor
Occidental Petroleum is set to achieve a 16% profit margin improvement
Valuation Occidental Petroleum (OXY) - Future Outlook 1. Business Position in 3, 5, or 10 Years Occidental Petroleum's future business position will likely be shaped by its core oil and gas operations, its aggressive push into carbon capture and storage (CCS), and its financial health.
View narrative
US$55.05
FV
21.1% undervalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
1
users have commented on this narrative
46
users have followed this narrative
about 2 months ago
author updated this narrative
Publicis Groupe
BR
Broke_Joe
Community Contributor
Publicis Groupe will Transform into a Tech-Forward Marketing Powerhouse
Publicis Groupe presents a compelling base case for medium-term investors, offering a well-balanced mix of defensive cash flow and exposure to structural growth trends in data, AI, and digital transformation. While historically viewed as a traditional advertising agency, Publicis has successfully repositioned itself over the past decade into a tech-enabled marketing and consulting powerhouse.
View narrative
€96.64
FV
17.6% undervalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 2 months ago
author updated this narrative
Space42
AL
ALPHA_AD1
Community Contributor
🚀 “Mission to Momentum: Why Space42’s True Orbit Is AED 6.43”
Narrative Valuation Summary Space42 is not your average growth story—it's a digital infrastructure powerhouse executing a high-velocity scale-up strategy. With a projected annual revenue growth of 67.8% , the company is expanding aggressively across digital platforms, cloud analytics, and AI-driven enterprise services.
View narrative
د.إ6.43
FV
66.3% undervalued
intrinsic discount
67.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
4
users have followed this narrative
about 2 months ago
author updated this narrative
Vita Life Sciences
RO
Robbo
Community Contributor
Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges
Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed Momentum Vita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and supplements across the Asia-Pacific region. Founded in 1947, the company boasts strong brand recognition through its labels such as VitaHealth, Herbs of Gold, VitaScience, and VitaLife, offering over 350 premium healthcare and pharmaceutical products.
View narrative
AU$2.42
FV
6.6% undervalued
intrinsic discount
12.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
2
users have commented on this narrative
30
users have followed this narrative
about 2 months ago
author updated this narrative
Value any company in seconds
Popular companies